Feb 05, 2025 8:00am EST Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment
Jan 22, 2025 8:00am EST Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
Dec 10, 2024 8:00am EST Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
Dec 04, 2024 8:00am EST Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
Nov 26, 2024 8:00am EST Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial